TechFlow news, September 29 — According to a post by Jia Yueting, Faraday Future's $30 million investment in QLGN is expected to be completed next week.
Faraday Future (NASDAQ: FFAI) announced on September 20 that it will strategically invest in Qualigen Therapeutics (NASDAQ: QLGN) through a PIPE transaction. The latter will be renamed CXC10 and transition into a crypto and Web3 business platform.




